Flagship Pioneering, LLC Long-Term Concentrated

Location: Cambridge, MA

CIK: 0001400240 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $9.549B (100.0% shares, 0.0% debt)

Holdings (13)

MRNA Moderna Inc 70.9%

Value $6.766B Shares 17,581,016 Est. Cost $16.43 Unrealized +2144.2%

SANA Sana Biotechnology Inc 8.1%

Value $771M Shares 34,239,018 Est. Cost $32.56 Unrealized -35.5%

— Rubius Therapeutics Inc 7.2%

Value $688M Shares 38,506,526 Est. Cost $24.00 Unrealized —

— Omega Therapeutics Inc 5.1%

Value $488M Shares 25,902,269 Est. Cost $18.85 Unrealized —

FHTX Foghorn Therapeutics Inc 1.8%

Value $177M Shares 12,674,120 Est. Cost $19.16 Unrealized -42.2%

— Evelo Biosciences Inc 1.7%

Value $162M Shares 23,030,069 Est. Cost $10.39 Unrealized —

DNLI Denali Therapeutics Inc 1.4%

Value $138M Shares 2,730,263 Est. Cost $17.97 Unrealized +213.6%

KLDO Kaleido Biosciences Inc 1.1%

Value $107M Shares 19,575,710 Est. Cost $13.01 Unrealized -52.3%

— Seres Therapeutics Inc 1.0%

Value $100M Shares 14,378,802 Est. Cost $8.55 Unrealized —

— Sigilon Therapeutics Inc 0.6%

Value $58.59M Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Codiak Biosciences Inc 0.4%

Value $42.58M Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Axcella Health Inc 0.4%

Value $37.39M Shares 12,548,414 Est. Cost $8.17 Unrealized —

— Syros Pharmaceuticals Inc 0.1%

Value $13.13M Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	17,581,016	$6.766B	70.9%	$16.43	+2144.2%	COM	60770K107
SANA	Sana Biotechnology Inc	34,239,018	$771M	8.1%	$32.56	-35.5%	COM	799566104
—	Rubius Therapeutics Inc	38,506,526	$688M	7.2%	$24.00	—	COM	78116T103
—	Omega Therapeutics Inc	25,902,269	$488M	5.1%	$18.85	—	COM	68217N105
FHTX	Foghorn Therapeutics Inc	12,674,120	$177M	1.8%	$19.16	-42.2%	COM	344174107
—	Evelo Biosciences Inc	23,030,069	$162M	1.7%	$10.39	—	COM	299734103
DNLI	Denali Therapeutics Inc	2,730,263	$138M	1.4%	$17.97	+213.6%	COM	24823R105
KLDO	Kaleido Biosciences Inc	19,575,710	$107M	1.1%	$13.01	-52.3%	COM	483347100
—	Seres Therapeutics Inc	14,378,802	$100M	1.0%	$8.55	—	COM	81750R102
—	Sigilon Therapeutics Inc	10,370,369	$58.59M	0.6%	$48.03	—	COM	82657L107
—	Codiak Biosciences Inc	2,607,303	$42.58M	0.4%	$32.30	—	COM	192010106
—	Axcella Health Inc	12,548,414	$37.39M	0.4%	$8.17	—	COM	05454B105
—	Syros Pharmaceuticals Inc	2,938,494	$13.13M	0.1%	$13.87	—	COM	87184Q107